43 related articles for article (PubMed ID: 38547077)
21. Co-treatment with a C1B5 peptide of protein kinase Cγ and a low dose of gemcitabine strongly attenuated pancreatic cancer growth in mice through T cell activation.
Ishiguro S; Kawabata A; Zulbaran-Rojas A; Monson K; Uppalapati D; Ohta N; Inui M; Pappas CG; Tzakos AG; Tamura M
Biochem Biophys Res Commun; 2018 Jan; 495(1):962-968. PubMed ID: 29155177
[TBL] [Abstract][Full Text] [Related]
22. Cholecystokinin receptor antagonist alters pancreatic cancer microenvironment and increases efficacy of immune checkpoint antibody therapy in mice.
Smith JP; Wang S; Nadella S; Jablonski SA; Weiner LM
Cancer Immunol Immunother; 2018 Feb; 67(2):195-207. PubMed ID: 29043413
[TBL] [Abstract][Full Text] [Related]
23. Gemcitabine mono-therapy versus gemcitabine plus targeted therapy in advanced pancreatic cancer: a meta-analysis of randomized phase III trials.
Ottaiano A; Capozzi M; De Divitiis C; De Stefano A; Botti G; Avallone A; Tafuto S
Acta Oncol; 2017 Mar; 56(3):377-383. PubMed ID: 28256961
[TBL] [Abstract][Full Text] [Related]
24. PD-1 and its ligands are important immune checkpoints in cancer.
Dong Y; Sun Q; Zhang X
Oncotarget; 2017 Jan; 8(2):2171-2186. PubMed ID: 27974689
[TBL] [Abstract][Full Text] [Related]
25. Host sphingosine kinase 1 worsens pancreatic cancer peritoneal carcinomatosis.
Aoki H; Aoki M; Katsuta E; Ramanathan R; Idowu MO; Spiegel S; Takabe K
J Surg Res; 2016 Oct; 205(2):510-517. PubMed ID: 27664902
[TBL] [Abstract][Full Text] [Related]
26. TGF-β Blockade Reduces Mortality and Metabolic Changes in a Validated Murine Model of Pancreatic Cancer Cachexia.
Greco SH; Tomkötter L; Vahle AK; Rokosh R; Avanzi A; Mahmood SK; Deutsch M; Alothman S; Alqunaibit D; Ochi A; Zambirinis C; Mohaimin T; Rendon M; Levie E; Pansari M; Torres-Hernandez A; Daley D; Barilla R; Pachter HL; Tippens D; Malik H; Boutajangout A; Wisniewski T; Miller G
PLoS One; 2015; 10(7):e0132786. PubMed ID: 26172047
[TBL] [Abstract][Full Text] [Related]
27. Novel pancreatic cancer cell lines derived from genetically engineered mouse models of spontaneous pancreatic adenocarcinoma: applications in diagnosis and therapy.
Torres MP; Rachagani S; Souchek JJ; Mallya K; Johansson SL; Batra SK
PLoS One; 2013; 8(11):e80580. PubMed ID: 24278292
[TBL] [Abstract][Full Text] [Related]
28. Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer.
Harder J; Ihorst G; Heinemann V; Hofheinz R; Moehler M; Buechler P; Kloeppel G; Röcken C; Bitzer M; Boeck S; Endlicher E; Reinacher-Schick A; Schmoor C; Geissler M
Br J Cancer; 2012 Mar; 106(6):1033-8. PubMed ID: 22374460
[TBL] [Abstract][Full Text] [Related]
29. Cell-delivered magnetic nanoparticles caused hyperthermia-mediated increased survival in a murine pancreatic cancer model.
Basel MT; Balivada S; Wang H; Shrestha TB; Seo GM; Pyle M; Abayaweera G; Dani R; Koper OB; Tamura M; Chikan V; Bossmann SH; Troyer DL
Int J Nanomedicine; 2012; 7():297-306. PubMed ID: 22287840
[TBL] [Abstract][Full Text] [Related]
30. Myxoma virus sensitizes cancer cells to gemcitabine and is an effective oncolytic virotherapeutic in models of disseminated pancreatic cancer.
Wennier ST; Liu J; Li S; Rahman MM; Mona M; McFadden G
Mol Ther; 2012 Apr; 20(4):759-68. PubMed ID: 22233582
[TBL] [Abstract][Full Text] [Related]
31. Genomic sequencing of key genes in mouse pancreatic cancer cells.
Wang Y; Zhang Y; Yang J; Ni X; Liu S; Li Z; Hodges SE; Fisher WE; Brunicardi FC; Gibbs RA; Gingras MC; Li M
Curr Mol Med; 2012 Mar; 12(3):331-41. PubMed ID: 22208613
[TBL] [Abstract][Full Text] [Related]
32. Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial.
Von Hoff DD; Ramanathan RK; Borad MJ; Laheru DA; Smith LS; Wood TE; Korn RL; Desai N; Trieu V; Iglesias JL; Zhang H; Soon-Shiong P; Shi T; Rajeshkumar NV; Maitra A; Hidalgo M
J Clin Oncol; 2011 Dec; 29(34):4548-54. PubMed ID: 21969517
[TBL] [Abstract][Full Text] [Related]
33. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.
Conroy T; Desseigne F; Ychou M; Bouché O; Guimbaud R; Bécouarn Y; Adenis A; Raoul JL; Gourgou-Bourgade S; de la Fouchardière C; Bennouna J; Bachet JB; Khemissa-Akouz F; Péré-Vergé D; Delbaldo C; Assenat E; Chauffert B; Michel P; Montoto-Grillot C; Ducreux M; ;
N Engl J Med; 2011 May; 364(19):1817-25. PubMed ID: 21561347
[TBL] [Abstract][Full Text] [Related]
34. Pancreas organogenesis: from bud to plexus to gland.
Pan FC; Wright C
Dev Dyn; 2011 Mar; 240(3):530-65. PubMed ID: 21337462
[TBL] [Abstract][Full Text] [Related]
35. Cytotherapy with naive rat umbilical cord matrix stem cells significantly attenuates growth of murine pancreatic cancer cells and increases survival in syngeneic mice.
Doi C; Maurya DK; Pyle MM; Troyer D; Tamura M
Cytotherapy; 2010 May; 12(3):408-17. PubMed ID: 20345214
[TBL] [Abstract][Full Text] [Related]
36. A prospective, non-randomized phase II trial of Trastuzumab and Capecitabine in patients with HER2 expressing metastasized pancreatic cancer.
Mihaljevic A; Büchler P; Harder J; Hofheinz R; Gregor M; Kanzler S; Schmiegel W; Heinemann V; Endlicher E; Klöppel G; Seufferlein T; Geissler M
BMC Surg; 2009 Jan; 9():1. PubMed ID: 19133157
[TBL] [Abstract][Full Text] [Related]
37. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice.
Hingorani SR; Wang L; Multani AS; Combs C; Deramaudt TB; Hruban RH; Rustgi AK; Chang S; Tuveson DA
Cancer Cell; 2005 May; 7(5):469-83. PubMed ID: 15894267
[TBL] [Abstract][Full Text] [Related]
38. Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice.
Corbett TH; Roberts BJ; Leopold WR; Peckham JC; Wilkoff LJ; Griswold DP; Schabel FM
Cancer Res; 1984 Feb; 44(2):717-26. PubMed ID: 6692374
[TBL] [Abstract][Full Text] [Related]
39. Inoculation of Pan02 cells produces tumor nodules in mouse pancreas: Characterization of a novel orthotopic pancreatic ductal adenocarcinoma tumor model for interventional studies.
Griffin JI; Chen X; Duan L; Mu Q; Ho RJY
PLoS One; 2024; 19(3):e0300723. PubMed ID: 38547077
[TBL] [Abstract][Full Text] [Related]
40. A starring role for stellate cells in the pancreatic cancer microenvironment.
Apte MV; Wilson JS; Lugea A; Pandol SJ
Gastroenterology; 2013 Jun; 144(6):1210-9. PubMed ID: 23622130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
